Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-27

Clinical Trial Update: Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria [Phase 3]

View source ↗

Summary

Phase 3 trial comparing JDP-205 to diphenhydramine injection for acute urticaria has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenhydramine (diphenhydramine)
  • JDP-205

Snippet

Sponsor: JDP Therapeutics, Inc. | Conditions: Acute Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2019-11-27